deal
Abiogen acquires EffRx to fortify bone disease portfolio
The Italian pharmaceutical company Abiogen Pharma acquired Effrx Pharmaceuticals, taking a step towards global expansion.
Marker to offload cell manufacturing assets to CellReady
Anabios boosts human tissue and cells portfolio with Cell Systems deal
ALPA executes merger agreement with Carmell Therapeutics
Lilly and ProQR to expand genetic medicine development agreement
Merck and Kelun-Biotech enter ADC development deal
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
